GlaxoSmithKline Pharmaceutical Sdn Bhd (GSK) today announced that Arexvy (MAL24086007ARZ) has been approved in Malaysia for ...
GlaxoSmithKline Pharmaceutical Sdn Bhd (GSK) today announced that the Arexvy vaccine (MAL24086007ARZ) has been approved in Malaysia for respiratory syncytial virus (RSV). RSV is a common respiratory ...
In a recent legal development, Hindustan Unilever (NS: HLL) faced a setback regarding a tax dispute involving a significant ...
Each year, up to 160,000 older adults in the United States are hospitalized due to respiratory syncytial virus, or RSV, and as many as 10,000 die from the disease. In 2023, a new vaccine was approved ...
The "Typhoid Fever - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering.Comprehensive insights into the future of typhoid fever treatment are now available, exploring ...
On3 on MSN10h
Report: FedEx continuing to reduce sponsorship presence with Joe Gibbs Racing, could sever ties altogetherFedEx is reportedly set to continue reducing its sponsorship presence with Joe Gibbs Racing after this season, with the ...
Arexvy has been approved in Malaysia for RSV (respiratory syncytial virus), for older adults aged 60 and above. The vaccine ...
Cancer Vaccines Market revenue is expected to hold around USD 24.22 billion by 2033 from USD 9 million in 2023 with a ...
Biogen and Belgian partner UCB said on Tuesday their experimental lupus treatment met the main goal of a late-stage trial in ...
15hon MSN
Sanofi has received two separate bids from private equity firms for its consumer health unit, which could be valued at 15 ...
The application of IT for protecting and improving people’s health and the implementation of electronic medical records (EMR) ...
Dr. Pham Thi My Lien, president of GSK Vietnam, spoke with VIR’s Bich Thuy about the importance of adult vaccinations, one of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback